ISOLATION OF THERAPEUTIC TARGET SPECIFIC VNAR DOMAINS TO ICOSL

Caroline Barelle (Inventor), Jonathan James William Finlay (Inventor), Alfredo Darmanin-Sheehan (Inventor)

Research output: Patent

Abstract

The present invention provides ICOSL specific antigen binding molecules which are isolated from immunized and synthetic Elasmobranchii derived libraries. In particular, the present invention relates to shark Variable New Antigen Receptor (VNAR) domains that specifically bind and neutralize the activity of human Induced Co-Stimulatory Ligand (ICOSL). The neutralizing VNAR domains are isolated from two independent sources; an immunized nurse shark library and a synthetic spiny dogfish framework fusion library. The molecules may be formulated as pharmaceutical compositions and used in medicine.
Original languageEnglish
IPCC07K16/00; C07K16/18; C12N15/13
Priority date23/04/13
Publication statusPublished - 30 Oct 2014

Fingerprint Dive into the research topics of 'ISOLATION OF THERAPEUTIC TARGET SPECIFIC VNAR DOMAINS TO ICOSL'. Together they form a unique fingerprint.

  • Cite this

    Barelle, C., Finlay, J. J. W., & Darmanin-Sheehan, A. (2014). IPC No. C07K16/00; C07K16/18; C12N15/13. ISOLATION OF THERAPEUTIC TARGET SPECIFIC VNAR DOMAINS TO ICOSL.